PFIZER INC — Director's Dealing 2018

Feb 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2018-02-22

Reporting Person: CANGIALOSI LORETTA V (Sr. Vice President, Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-22	Common Stock	A	4166.0000	$0.0000	Acquired	88481.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-22	Stock Appreciation Rights	$35.7400	A	21673.0000	Acquired	2023-02-22	Common Stock (21673.0000)	Direct
2018-02-22	Stock Appreciation Rights	$35.7400	A	18119.0000	Acquired	2025-02-22	Common Stock (18119.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1574.0000	Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.